Global Veterinary Diagnostics Market to Reach USD 23.99 Billion by 2034, Growing at 10.56% CAGR
Veterinary Diagnostics Market: Rising Pet Healthcare Spending and Advanced Disease Detection Technologies to Accelerate Industry Growth
Market Estimation and Growth Drivers
The global Veterinary Diagnostics Market was valued at USD 9.72 billion in 2025 and is projected to reach USD 23.99 billion by 2034, registering a compound annual growth rate (CAGR) of 10.56% during the forecast period from 2026 to 2034. Veterinary diagnostics involves testing technologies and services used to detect, monitor, and manage diseases in companion animals, livestock, and other species. The market includes consumables, reagents and kits, diagnostic instruments, molecular testing, immunoassays, imaging, and laboratory services.
Increasing pet ownership, rising expenditure on animal healthcare, and growing awareness of preventive veterinary medicine are major factors supporting market expansion. The rising incidence of infectious and zoonotic diseases is also increasing the need for reliable diagnostic testing and continuous animal health surveillance. Livestock producers are adopting diagnostic solutions to improve herd health, reduce production losses, and support food safety. Technological developments in molecular diagnostics, automated testing systems, rapid point-of-care devices, and AI-enabled image analysis are improving testing speed and accuracy. These developments create opportunities for companies offering affordable in-clinic testing, advanced laboratory platforms, and integrated digital diagnostic services.
* Gain Competitive Market Advantage: https://www.maximizemarketresearch.com/request-sample/34589/
United States Market: Investment in Advanced Veterinary Diagnostics
The United States remains a major market for veterinary diagnostics, supported by high pet healthcare expenditure, advanced veterinary infrastructure, and investments in laboratory networks and early disease detection. In January 2025, IDEXX Laboratories announced the launch of IDEXX Cancer Dx, a diagnostic blood panel designed to support early detection of canine lymphoma. The test became available through its North American reference laboratories in March 2025, expanding opportunities for preventive veterinary screening. In May 2025, Zoetis announced the opening of its new state-of-the-art veterinary diagnostics reference laboratory in Louisville, Kentucky. The facility strengthened the company's U.S. laboratory network through expanded testing capacity, logistics, and diagnostic services. These investments demonstrate the growing emphasis on early diagnosis, faster laboratory results, and accessible testing solutions. Government-supported disease surveillance initiatives, including the USDA's National Animal Health Laboratory Network, further reinforce the importance of diagnostic infrastructure in protecting animal and public health.
Market Segmentation Analysis
The Veterinary Diagnostics Market is segmented by product, species, testing type, disease type, and end use. Product categories include consumables, reagents and kits, and instruments and devices. Species covered include cattle, canine, feline, caprine, equine, ovine, porcine, avian, and others. Testing types include analytical services, diagnostic imaging, bacteriology, pathology, molecular diagnostics, immunoassays, parasitology, serology, and virology. Disease categories cover infectious diseases, non-infectious diseases, hereditary, congenital and acquired diseases, general ailments, and structural and functional diseases.
By testing type, immunoassays dominated the market in 2025, supported by their broad application in identifying infectious diseases, hormonal conditions, and metabolic disorders. Their rapid results, cost-effectiveness, and suitability for laboratory and point-of-care testing encourage widespread adoption. By end use, laboratories held approximately 49% of the market in 2025, making them the leading segment. National, state, and private laboratories play an essential role in disease surveillance, diagnostic testing, research, quality assurance, and monitoring of transboundary animal diseases. Veterinary hospitals and clinics, point-of-care facilities, and research institutes also represent important end-use categories.
Key Players
North America
- IDEXX Laboratories Inc. (USA)
2. Zoetis Services LLC (USA)
3. Heska Corporation (USA)
4. Thermo Fisher Scientific, Inc. (USA)
5. Antech Diagnostics Inc. (Mars, Inc.) (USA)
6. VCA Animal Hospitals (Mars, Inc.) (USA)
7. Neogen Corporation (USA)
Europe
8. bioMérieux SA (France)
9. Virbac Corp (France)
10. Alvedia (France)
11. Randox Laboratories Ltd. (UK)
12. Biopanda Reagents (UK)
13. INDICAL BIOSCIENCE GmbH (Germany)
14. Fassisi GmbH (Germany)
15. QIAGEN N.V. (Germany)
16. Agrolabo S.p.A. (Italy)
Asia-Pacific
17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
18. Shenzhen Bioeasy Biotechnology Co. Ltd. (China)
19. BioNote Inc. (South Korea)
20. FUJIFILM Holdings Corporation (Japan)
21. IM3Vet Pty Ltd. (Australia)
Competitive Landscape and Key Companies
The global Veterinary Diagnostics Market includes established animal-health companies, laboratory service providers, and medical technology manufacturers. Five prominent companies identified in the report are IDEXX Laboratories Inc., Zoetis Services LLC, Heska Corporation, Thermo Fisher Scientific Inc., and Antech Diagnostics Inc. The report does not provide individual market-share percentages or a definitive ranking among these five companies.
IDEXX Laboratories is strengthening its diagnostic portfolio through early cancer detection, automated analyzers, and laboratory testing services. Its 2025 Cancer Dx launch represents an important development in preventive canine healthcare. Zoetis is investing in reference laboratory infrastructure and point-of-care testing, including its Vetscan OptiCell hematology analyzer, which combines artificial intelligence with automated blood analysis. Heska, now part of Mars Petcare, contributes point-of-care diagnostic instruments and veterinary testing solutions. Thermo Fisher Scientific supports the market through molecular diagnostic technologies, laboratory equipment, and testing solutions. Antech Diagnostics, part of Mars' Science and Diagnostics division, is advancing AI-supported veterinary imaging and cancer screening technologies. Its AIS RapidRead and Nu.Q cancer screening solutions illustrate the industry's movement toward faster diagnostic interpretation and earlier disease identification. Continued investment in automation, AI, molecular testing, and laboratory networks is expected to intensify competition.
Regional Analysis
North America dominated the global Veterinary Diagnostics Market in 2025, supported by advanced veterinary healthcare infrastructure, high companion-animal healthcare spending, established diagnostic laboratories, and strong research investment. The United States is the region's principal market, benefiting from private-sector innovation and government-supported animal disease surveillance.
In Europe, the United Kingdom, Germany, and France offer significant opportunities through established veterinary services, animal welfare standards, and disease monitoring systems. European Union animal-health legislation and surveillance frameworks support the detection and control of infectious diseases. Japan benefits from advanced laboratory technology, veterinary research capabilities, and demand for companion-animal healthcare. China represents a growth opportunity through expanding veterinary infrastructure, livestock disease monitoring, and rising demand for animal health products. Although North America leads regionally, the public report does not disclose individual market-share percentages for these countries.
Related Reports:
Veterinary Dental Equipment Market https://www.maximizemarketresearch.com/market-report/veterinary-dental-equipment-market/249639/
Phytoestrogen Supplements Market https://www.maximizemarketresearch.com/market-report/phytoestrogen-supplements-market/259141/
Global Guillain Barr syndrome treatment Market https://www.maximizemarketresearch.com/market-report/global-guillain-barre-syndrome-treatment-market/38724/
Conclusion
The Veterinary Diagnostics Market is positioned for strong growth as animal healthcare increasingly shifts toward preventive testing, early disease detection, and technology-enabled veterinary services. Immunoassays and laboratory-based testing currently provide important foundations for market demand, while molecular diagnostics, AI-powered platforms, and point-of-care solutions offer substantial opportunities for future innovation. Increasing investment in diagnostic infrastructure, rising pet ownership, and stronger surveillance of zoonotic diseases are expected to remain key growth drivers. Companies that combine accurate testing, rapid results, accessible pricing, and integrated diagnostic services will be well positioned to benefit from the expanding global animal healthcare industry.
About Maximize Market Research
Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.
Contact Maximize Market Research
MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
? +91 9607365656
? sales@maximizemarketresearch.com
